9月9日，10x Genomics盘中上涨5.01%，报65.85美元/股，成交额8309.43万美元。
消息面上，加拿大皇家银行（RBC）近日首次覆盖10x Genomics，给予行业表现评级，并设定70美元目标价，远高于市场一致预期的51美元。RBC指出公司在高通量空间分子分析领域拥有超60%市场份额，空间业务仍处于早期渗透阶段，保持两位数增长。此外，公司近日披露13G/A持仓变动报告，显示重要投资者持仓调整，进一步引发市场关注。基本面上，公司Q2每股亏损0.14美元，优于市场预期的亏损0.24美元，营收1.51亿美元亦超预期，全年营收指引上调至6.1亿至6.3亿美元。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.